Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Momentum oscillators indicate that the stock has the potential to move higher towards its target of Rs 2822 in the near-term.
Ashwani Gujral of ashwanigujral.com recommends buying YES Bank with a stop loss of Rs 208, target of Rs 224, Reliance Industries with a stop loss of Rs 1235, target of Rs 1285 and Rural Electrification Corporation with a stop loss of Rs 118, target of Rs 130.
Mitessh Thakkar of mitesshthakkar.com recommends buying Amara Raja Batteries with stop loss of Rs 770 and target of Rs 805, Dr Reddy's Labs with a stop loss of Rs 2619 and target of Rs 2700 and Wipro with a stop loss below Rs 340 for target of Rs 360.
Mitessh Thakkar of mitesshthakkar.com recommends buying Dr Reddy's Labs with a stop loss of Rs 2592 and target of Rs 2680, Lupin with a stop loss of Rs 851.5 and target of Rs 890 and Finolex Industries with a stop loss of Rs 547 and target of Rs 585.
Mitessh Thakkar of miteshthacker.com recommends buying Cummins India with a stop loss below Rs 839 for target of Rs 900, Glenmark Pharma with a stop loss of Rs 685 and target of Rs 720 and M&M with a stop loss of Rs 792 and target of Rs 830.
Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Laboratories with stop loss at Rs 2645 and target of Rs 2735, Tech Mahindra with stop loss at Rs 678 and target off Rs 705 and Hero MotoCorp with stop loss at Rs 3000 and target of Rs 3080.
In coming week any tick above 9,350 on Nifty Pharma index will trigger fresh buying in pharma stocks, Arpan Shah of Monarch Networth Capital said
Sudarshan Sukhani of s2analytics.com suggests buying Maruti Suzuki with stop loss at Rs 7570 and target of Rs 7800, Century Textiles with stop loss at Rs 905 and target of Rs 965 and Cadila Healthcare with stop loss at Rs 354 and target of Rs 382.
We recommend traders to buy this stock in the range of Rs 2650 to 2625 with a price target of Rs 2900 and a stop loss placed below Rs 2520, says Aditya Agarwal of Way2Wealth Brokers.
Rajesh Agarwal of AUM Capital recommends buying Max Financial Services with stop loss at Rs 437 and target of Rs 462, Escorts with stop loss at Rs 685 and target of Rs 708 and TVS Motor Company with stop loss at Rs 539 and target of Rs 563.
On Friday, Nifty November futures closed at 10,518, however, the index is trading below its max pain strike level of 10,600 for the first time in this series
Analysts expect Dr Reddy's to make around $50-75 million in rest of FY19. Dr Reddy's had booked sales of around $10-$15 million in a matter of a few days after its launch, before it was stayed by the court.
Mitessh Thakkar of mitesshthakkar.com suggests buying Reliance Industries around Rs 1145 with stop loss of Rs 1130 for target of Rs 1180 and Apollo Hospitals around Rs 1215 with stop loss of Rs 1199 and target of Rs 1255.
Ashwani Gujral of ashwanigujral.com suggests buying United Spirits with a stop loss of Rs 556, target of Rs 580, Arvind with a stop loss of Rs 340, target of Rs 357 and Hindustan Unilever with a stop loss of Rs 1580, target of Rs 1640.
HDFC Securities has selected the stock on two criteria – capital preservation (for now) and alpha generation (for later).
Ashwani Gujral of ashwanigujral.com advises buying Adani Enterprises with a stoploss of Rs 148 and target of Rs 160.
Sudarshan Sukhani of s2analytics.com suggests buying Apollo Hospitals with stop loss at Rs 1070 and target of Rs 1120, Aurobindo Pharma with stop loss at Rs 740 and target of Rs 794 and Tata Consultancy Services with stop loss at Rs 2050 and target of Rs 2200.
Our strategy should be to hide ourselves in the defensive sector till the Nifty does not cross the all-time high level of 11,770.
These include names such as IOC, BPCL, Hero MotoCorp, Shree Cements, Ambuja Cements, Havells India, HPCL, ACC, Exide Industries, IGL, and Amara Raja Batteries.
Goldman Sachs, which was strategically overweight on India since March 2014, has turned slightly cautious towards Indian market in 2018 and lowered its investment view to marketweight from overweight earlier.
Mitessh Thakkar of mitesshthakkar.com recommends buying Biocon with a stop loss of Rs 663 and target of Rs 705 and advises selling Container Corporation of India with a stop loss of Rs 628 and target of Rs 585 and Oriental Bank of Commerce with a stop loss of Rs 75.1 and target of Rs 68.
Rahul Mohindar of viratechindia.com is of the view that one can sell Tata Consultancy Services with target of Rs 2085 and stop loss at Rs 2085 and buy Dr Reddy's Laboratories with target of Rs 2680 and stop loss at Rs 2460.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Bharat Forge above Rs 695, stop loss of Rs 682 and target of Rs 720 and Bharti Airtel with a stop loss of Rs 384 and target of Rs 400 and can sell Just Dial with a stop loss of Rs 547.5 and target of Rs 515.
We advocate traders to buy Dr. Reddy in a range of Rs 2,580 to Rs 2,530 with an upside price target of Rs 2,760. A stop loss should be placed at Rs 2,460.
On the higher side, call writing at 11,700-11,800 will act as stiff resistance zone for the index and a close above 11,800 will only negate bearish view on indices.